Adalimumab-induced sensory vasculitic neuropathy.
Autor: | Sim NK; Department of Neurology, Calderdale and Huddersfield NHS Foundation Trust, Halifax, UK nicholas.sim1@nhs.net., Ismail A; Department of Pathology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Alam T; Department of Clinical Neurophysiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Shanmugarajah PD; Department of Neurology, Leeds Teaching Hospitals NHS Trust, Leeds, UK. |
---|---|
Jazyk: | angličtina |
Zdroj: | Drug and therapeutics bulletin [Drug Ther Bull] 2023 Sep; Vol. 61 (9), pp. 140-143. Date of Electronic Publication: 2023 Jan 17. |
DOI: | 10.1136/dtb.2022.246401.rep |
Abstrakt: | Competing Interests: Competing interests: None declared. |
Databáze: | MEDLINE |
Externí odkaz: |